| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +10K | 100% | $6.70 | +$67K |
| Sells | 0 | ||||
| Net | +1 | +10K | 100% | +$67K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| James C. Clemmer | President and CEO, Director | $4.52M | +$67K | +1.5% | Jul 20, 2024 |
| Dennis S. Meteny | Director | $1.21M | Jul 19, 2023 | ||
| Stephen A. Trowbridge | EVP and CFO | $1.19M | Jul 20, 2024 | ||
| Howard W. Donnelly | Director | $1M | Jul 17, 2024 | ||
| Wesley Johnson | Director | $843K | Jul 17, 2024 | ||
| Jan Stern Reed | Director | $585K | Jul 17, 2024 | ||
| Eileen O'Shea Auen | Director | $583K | Jul 17, 2024 | ||
| Scott Centea | Svp/Gm, Vit | $545K | Jul 20, 2023 | ||
| Karen A. Licitra | Director | $487K | Jul 17, 2024 | ||
| Chad Thomas Campbell | SVP/GM, Vascular Access | $453K | Jul 20, 2024 | ||
| Michael E. Tarnoff | Director | $440K | Jul 17, 2024 | ||
| Dave Helsel | SVP Global Operations and R&D | $298K | Jul 20, 2023 | ||
| Warren Nighan JR | SVP Quality and Regulatory | $292K | Jul 20, 2024 | ||
| Laura Piccinini | SVP International | $271K | Jul 20, 2024 | ||
| Lorinda Burgess | Director | $252K | Jul 17, 2024 | ||
| Richard C. Rosenzweig | SVP and General Counsel | $136K | Feb 1, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|